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Sepsis caused by Listeria monocytogenes 
during chemotherapy for small cell carcinoma 
of the thymus
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Abstract 
Background: Listeria monocytogenes is a facultative intracellular parasitic bacterium that is Gram positive, catalase 
positive, oxidase negative, and a facultative anaerobe. It is known to infect humans through food. It is a bacillus with 
low virulence, but can cause meningitis and sepsis in infants and immunocompromised patients.
Case presentation: A case of 75-year-old Japanese female with small cell carcinoma of the thymus and pleural dis-
semination is described. She was treated with carboplatin and etoposide and showed a partial response. However, 
the tumor recurred 6 months later. Therefore, we again administered carboplatin and etoposide. Though peritoneal 
dissemination was suspected based on abdominal computed tomography findings after two courses, the assessment 
was stable disease. She was occasionally treated for constipation. She developed chills, rigor, and diarrhea, necessitat-
ing admission on the 7th day of the third course of chemotherapy. We suspected intestinal infection, and cefepime 
was thus administered. However, her blood pressure dropped and neutropenia manifested on the 4th day of admis-
sion. We therefore switched the antibiotic from cefepime to meropenem and also administered granulocyte-colony 
stimulating factor. Listeria monocytogenes was detected by two blood cultures, and the antimicrobial medication was 
thus switched to ampicillin, in consideration of sensitivity. Her general condition improved and she was able to leave 
the hospital on the 19th day after admission.
Conclusions: During chemotherapy, factors such as impaired bowel movements, malnutrition, and myeloablation 
can contribute to the development of severe infections. It is necessary to comprehensively assess a patient’s state and 
treat all aspects of illness.
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Background
Listeria monocytogenes (L. monocytogenes) is a facultative 
intracellular bacterium that is Gram positive, catalase 
positive, oxidase negative, and a facultative anaerobe. L. 
monocytogenes is known to infect humans through food 
including cheese and fresh vegetables [1]. It is a bacillus 
with low virulence, and this infection is rare in adults 
without underlying diseases, but it can cause meningitis 
and sepsis in infants and the elderly, as well as in immu-
nocompromised patients [2]. There are some reports 
of Listeriosis in Japan, in the compromised host dur-
ing chemotherapy [3] and after surgery [4, 5]. In a Japa-
nese review of listeriosis cases over for 23  years, it was 
reported that 76.4% of deaths in adult cases had underly-
ing conditions [6].
We experienced a case of sepsis caused by L. monocy-
togenes during chemotherapy for small cell carcinoma of 
the thymus. This case is reported with a discussion of the 
relevant literature.
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Case presentation
The patient was a 75-year-old Japanese female who pre-
sented with chief complaints of fever and diarrhea. The 
past history, family history, and personal/occupational 
history were unremarkable. A diagnosis of small cell car-
cinoma of the thymus (cT4N2M1 stage IV) was made on 
January 19, 2010. Chemotherapy was started with carbo-
platin (CBDCA) + etoposide (VP-16) (Chemotherapy for 
small cell carcinoma of the thymus has not established. 
We performed the chemotherapy for small cell of the thy-
mus using the regimen for small cell lung carcinoma as 
reference.) on the same day, and a total of four courses 
were administered. The tumor decreased in size following 
this treatment and the response was assessed as partial 
response (PR). Relapse of the tumor was detected in July, 
and chemotherapy with CBDCA + VP-16 was resumed 
due to sensitive relapse. Findings on chest-abdominal 
computed tomography (CT) performed for evaluation 
on October 12 after two courses of treatment suggested 
the possibility of peritoneal dissemination. However, the 
tumor response was assessed as stable disease (SD), and 
the treatment was continued. While receiving this treat-
ment, the patient complained of constipation, which was 
dealt with symptomatically. On December 21 (the 7th 
day of the third course of chemotherapy), the patient 
developed chills, fever, and diarrhea, and was admitted 
on December 22 with a diagnosis of severe infection as 
an adverse event during chemotherapy. Vital signs were 
normal, except for a body temperature of 38.7°C. Chest 
auscultation revealed no abnormal findings. Examination 
of the abdomen also revealed no abnormalities, except 
for slight generalized tenderness. Laboratory examina-
tion revealed the following: hematology: pancytopenia 
(WBC 2,900/μL, RBC 335 ×  104/μL, Hb 10.2  g/dL, Plt 
10.1  ×  104/μL); blood biochemistry: slight deteriora-
tion of liver function and electrolyte abnormalities (AST 
37 U/L, ALT 30 U/L, LDH 250 U/L, ALP 454 U/L, γ-GTP 
214 U/L, Na 132 mmol/L, Cl 95 mmol/L), and significant 
increase in serum CRP (CRP 32.76 mg/dL); blood coag-
ulation profile: elevation of serum levels of FDP (FDP 
22.5  μg/mL); serum tumor marker levels: within nor-
mal range. Arterial blood gas analysis revealed evidence 
of respiratory alkalosis (pH 7.532, pCO2 28.5 Torr, pO2 
70.4  Torr, HCO3 23.8  mmol/L). Although Enterococ-
cus faecalis was detected in the urine, urine microscopy 
revealed only 5-9 WBC/HPF, not suggestive of urinary 
tract infection (Table  1). Influenza test was negative. A 
chest X-ray revealed no abnormal findings (Figure  1). 
Chest CT showed an increase in the size of the small cell 
carcinoma tumor arising from the thymus in the anterior 
mediastinum (Figure  2a). Abdominal CT revealed mild 
ascites and prominent irregular granular shadows of the 
greater omentum and the mesentery (Figure 2b), sugges-
tive of peritoneal dissemination.
The focus of the infection was unclear, but since the 
patient was a compromised host, enteric bacterial infec-
tion was assumed and treatment was started empirically 
with cefepime (CFPM) 3 g/day. Samples were collected 
for two sets of blood culture at the time of admission. 
Because of a fall in blood pressure and neutropenia on 
December 25, the antimicrobial drug was switched to 
meropenem (MEPM) 1.5  g/day, and administration of 
Table 1 Laboratory data at initial visitation
CBC Blood chemistry Tumor marker
 WBC 2900/μL  AST 37 IU/L  NSE 8.4 ng/mL
  Neutro 92.5 %  ALT 30 IU/L  ProGRP 43.7 pg/mL
  Mono 0.3 %  Y-GTP 214 IU/L Urinalysis
 RBC 335 × 104/μL  LDH 250 IU/L  WBC 5–9/HPF
 Hb 10.2 g/dL  ALP 454 IU/L  E. faecalis 1 × 107
 Pit 10.1 × 104/μL  TP 6.7 g/dL Arterial blood gas analysis (room air)
Coagulation  Alb 3.4 g/dL  PH 7.532
 PT-INR 1.15  CK 21 IU/L  pCO2 28.5 Torr
 APTT 33.4 s  BUN 18 mg/dL  pO2 70.4 Torr
 Fibrinogen 352 mg/dL  Cre 0.66 mg/dL  HCO3 23.8 mmol/L
 FDP 22.5 μg/mL  Na 132 mmol/L  SaO2 95.5 %
 AT-III 85%  K 4.1 mmol/L Bacteriological examination
 CI 95 mmol/L  Blood L. monocytogenes (+)
 Ca 8.3 mmol/L
 CRP 32.76 mg/dL
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granulocyte-colony stimulating factor (G-CSF) was 
started. On December 26, L. monocytogenes was identi-
fied in both sets of blood culture bottle, in BacT/ALERT 
blood cultures by direct inoculation into the Vitek 2 
system (This serotype is not known.). On December 28, 
with recovery of the neutrophil count, the antibiotic 
was again changed to ampicillin (ABPC) 4 g/day in con-
sideration of the bacterial sensitivity. The patient then 
recovered gradually and was discharged on January 10, 
2011.
Discussion
L. monocytogenes is widely distributed throughout the 
environment including soil, water, and decaying vegeta-
tion. L. monocytogenes exists in the feces of animals and 
putrescent tissues, showing a high osmotic pressure 
tolerance and the ability to proliferate in temperatures 
ranging from 1 to 45°C [2]. The gastrointestinal mucous 
membrane is considered to be the most common source 
of infection [1].Figure 1 Chest X-ray showed no abnormal findings.
Figure 2 a Chest computed tomography showed an increase in the size of the small cell carcinoma tumor arising from the thymus (red circle). b 
Abdominal computed tomography showed mild ascites (red arrow) and prominent irregular granular shadows of the greater omentum and the 
mesentery (red circle).
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L. monocytogenes has the ability to pass the intesti-
nal barrier. The primary method of entry into endothe-
lial cells is believed to be via a zipper-like mechanism 
[7]. Invasion proteins on the surface of the bacteria, like 
Internalin A, Internalin B, and P60, help the bacterium 
bind to host surface receptors [8]. This ability is thought 
to trigger bacterial translocation (BT).
BT is considered to be the mechanism underlying 
sepsis due to L. monocytogenes. The phenomenon of 
enteral bacteria moving outside of the intestinal tract 
was described a century ago in animal experiments [9]. 
BT was defined as “the passage of viable bacteria from 
the gastrointestinal tract through the epithelial mucosa 
into the lamina propria and then to the mesenteric lymph 
nodes and possibly other organs” [10]. The intestinal 
tract then came to be thought of as a new source of infec-
tion. At present, microbial translocation, i.e., the concept 
of BT, is recognized as involving not only live bacteria 
but also components of dead bacteria and bacterial fac-
tors such as endotoxin [11]. L. monocytogenes is thought 
to invade intestinal epithelial cells and the mucous mem-
brane lamina propria via various routes and to become 
an internalization of macrophages and lymphocytes, sub-
sequently migrating to remote organs through lymphatic 
vessels [7].
The mechanisms of BT are considered to be (1) a 
change in enterobacterial flora, (2) failure of the intesti-
nal tract barrier, and (3) diminished host immunity. The 
enterobacterial flora maintains an equilibrium allowing 
fungi and bacteria to coexist. When this enterobacte-
rial flora balance is compromised by antimicrobials, 
antacids, ileus, or fecal impaction, pathogenic microbes 
and toxins proliferate abnormally in the intestinal tract, 
and this leads to contact with intestinal epithelia. The 
intestinal tract barrier is an epithelial structure that 
functions as a mechanical barrier and also provides a 
mucous membrane layer to protect the organism from 
excessive intestinal tract peristalsis and digestive juices 
such as gastric acid and bile acid. With the atrophy of 
intestinal tract disuse, ischemia may occur due to shock, 
malnutrition, hepatic cirrhosis, arterial clotting, inflam-
matory bowel disease, or radiation exposure, leading 
to barrier function failure, and pathogenic microbes 
can then come into contact with the intestinal mucosa. 
The intestinal mucosa then becomes hyper-permea-
ble, facilitating invasion by pathogenic microbes. The 
intestinal tract has an immunologic barrier function 
and harbors local immune factors including neutro-
phils, macrophages, and gut-associated lymphoid tissue 
(GALT) of the terminal ileum. GALT is the most immu-
nologically active tissue in the human body. Decreasing 
immune cells in GALT, due to nutritional management 
designed to avoid the gastrointestinal tract, reduces 
local immunity by causing IgA secretion disorders 
in the intestinal epithelia, compromised host immu-
nity, and diminished host immuno-responsiveness 
to invasive pathogens from the intestinal tract. These 
alterations can all promote invasion by pathogens. It is 
thought that myeloablation with chemotherapy and the 
associated reduction in host immunity, direct damage 
to the intestinal mucosa by chemotherapy, intestinal 
tract obstruction by tumors with peritoneal dissemi-
nation, and constipation due to impaired bowel move-
ments associated with disease states or treatment can 
lead to BT.
Normalization of the aforementioned processes is nec-
essary for the prevention and treatment of BT. In other 
words, for prevention of BT it is necessary to (1) con-
trol the enterobacterial flora, (2) maintain the intestinal 
tract barrier, (3) control immuno-responsiveness, and (4) 
maintain the intestinal tract blood supply. To achieve the 
prevention and treatment of BT, attention is being paid to 
the administration of probiotics and prebiotics [12, 13], 
glutamine [14], polyethylene glycol [15], and dobutamine 
[16]. In addition, to control immuno-responsiveness, 
endotoxin adsorption with blood adsorption therapy 
using a polymyxin B column was reported to be useful 
[17, 18].
As in our case, with the source of infection being 
unclear, the sepsis often progresses. BT is potentially 
involved in the infectious process by various mechanisms 
and must, in the intestinal tract, be regarded as an impor-
tant source of infection. Thus, it is necessary to prevent 
BT as well as to implement infection control procedures.
Conclusion
We encountered a case with sepsis caused by L. mono-
cytogenes during chemotherapy for small cell carcinoma 
of the thymus. We often experience unidentified sepsis 
during chemotherapy. Impaired bowel movements, mal-
nutrition, and myeloablation by chemotherapy can eas-
ily cause bacterial translocation. We must not forget the 
possibility of serious sepsis caused by L. monocytogenes 
through bacterial translocation during chemotherapy. It 
is necessary to comprehensively assess a patient’s state 
and treat all aspects of illness.
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